{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T14:49:27Z","timestamp":1793890167174,"version":"4.8.0"},"reference-count":162,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100025520","name":"Medical Research Future Fund","doi-asserted-by":"publisher","award":["MRF2007656"],"award-info":[{"award-number":["MRF2007656"]}],"id":[{"id":"10.13039\/501100025520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1194028"],"award-info":[{"award-number":["GNT1194028"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1123625"],"award-info":[{"award-number":["GNT1123625"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT2008359"],"award-info":[{"award-number":["GNT2008359"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Neurosciences"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.tins.2025.06.008","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T12:08:04Z","timestamp":1753099684000},"page":"750-765","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Triggering ferroptosis in neurodegenerative diseases"],"prefix":"10.1016","volume":"48","author":[{"given":"Triet P.M.","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darius J.R.","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley I.","family":"Bush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3479-2427","authenticated-orcid":false,"given":"Scott","family":"Ayton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tins.2025.06.008_bb0005","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","article-title":"Hallmarks of neurodegenerative diseases","volume":"186","author":"Wilson","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.tins.2025.06.008_bb0010","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.tins.2019.11.005","article-title":"Fiery cell death: pyroptosis in the central nervous system","volume":"43","author":"McKenzie","year":"2020","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.tins.2025.06.008_bb0015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41583-018-0093-1","article-title":"Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases","volume":"20","author":"Yuan","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tins.2025.06.008_bb0020","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nrn3228","article-title":"Apoptotic and non-apoptotic roles of caspases in neuronal physiology and pathophysiology","volume":"13","author":"Hyman","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tins.2025.06.008_bb0025","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.tins.2025.06.008_bb0030","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.tins.2025.06.008_bb0035","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.cell.2017.11.048","article-title":"Selenium utilization by GPX4 is required to prevent hydroperoxide-induced ferroptosis","volume":"172","author":"Ingold","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.tins.2025.06.008_bb0040","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cmet.2008.07.005","article-title":"Glutathione peroxidase 4 senses and translates oxidative stress into 12\/15-lipoxygenase dependent- and AIF-mediated cell death","volume":"8","author":"Seiler","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.tins.2025.06.008_bb0045","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.redox.2017.01.021","article-title":"Ablation of ferroptosis regulator glutathione peroxidase 4 in forebrain neurons promotes cognitive impairment and neurodegeneration","volume":"12","author":"Hambright","year":"2017","journal-title":"Redox Biol."},{"key":"10.1016\/j.tins.2025.06.008_bb0050","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.chembiol.2022.06.004","article-title":"Context-dependent regulation of ferroptosis sensitivity","volume":"29","author":"Magtanong","year":"2022","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.tins.2025.06.008_bb0055","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41589-022-01249-3","article-title":"Identification of essential sites of lipid peroxidation in ferroptosis","volume":"19","author":"von Krusenstiern","year":"2023","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.tins.2025.06.008_bb0060","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/s41589-019-0408-1","article-title":"The chemical basis of ferroptosis","volume":"15","author":"Conrad","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.tins.2025.06.008_bb0065","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41556-019-0305-6","article-title":"ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway","volume":"21","author":"Chu","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.tins.2025.06.008_bb0070","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/s41589-020-0472-6","article-title":"Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis","volume":"16","author":"Zou","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.tins.2025.06.008_bb0075","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/ncb3064","article-title":"Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice","volume":"16","author":"Friedmann Angeli","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.tins.2025.06.008_bb0080","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1001\/jamaneurol.2024.3733","article-title":"Deferiprone in Alzheimer disease: a randomized clinical trial","volume":"82","author":"Ayton","year":"2025","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.tins.2025.06.008_bb0085","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1056\/NEJMoa2209254","article-title":"Trial of deferiprone in Parkinson's disease","volume":"387","author":"Devos","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tins.2025.06.008_bb0090","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.nbd.2016.05.011","article-title":"Ferroptosis, a newly characterized form of cell death in Parkinson's disease that is regulated by PKC","volume":"94","author":"Do Van","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tins.2025.06.008_bb0095","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cmet.2024.10.006","article-title":"Microbiota-derived lysophosphatidylcholine alleviates Alzheimer's disease pathology via suppressing ferroptosis","volume":"37","author":"Zha","year":"2025","journal-title":"Cell Metab."},{"key":"10.1016\/j.tins.2025.06.008_bb0100","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.molcel.2023.03.005","article-title":"Ferroptosis: A flexible constellation of related biochemical mechanisms","volume":"83","author":"Dixon","year":"2023","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tins.2025.06.008_bb0105","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41392-024-02088-5","article-title":"In defence of ferroptosis","volume":"10","author":"Alves","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.tins.2025.06.008_bb0110","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/s41593-018-0242-x","article-title":"Microglia in neurodegeneration","volume":"21","author":"Hickman","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tins.2025.06.008_bb0115","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41593-022-01221-3","article-title":"Microglia ferroptosis is regulated by SEC24B and contributes to neurodegeneration","volume":"26","author":"Ryan","year":"2023","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tins.2025.06.008_bb0120","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13024-023-00691-8","article-title":"Microglial ferroptotic stress causes non-cell autonomous neuronal death","volume":"19","author":"Liddell","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tins.2025.06.008_bb0125","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.cell.2024.02.030","article-title":"Cellular architecture of evolving neuroinflammatory lesions and multiple sclerosis pathology","volume":"187","author":"Kukanja","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.tins.2025.06.008_bb0130","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/s43587-023-00479-x","article-title":"Transcriptional and epigenetic decoding of the microglial aging process","volume":"3","author":"Li","year":"2023","journal-title":"Nat. Aging"},{"key":"10.1016\/j.tins.2025.06.008_bb0135","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1016\/j.cell.2023.08.037","article-title":"Human microglial state dynamics in Alzheimer's disease progression","volume":"186","author":"Sun","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.tins.2025.06.008_bb0140","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1016\/j.celrep.2020.02.028","article-title":"Microglial homeostasis requires balanced CSF-1\/CSF-2 receptor signaling","volume":"30","author":"Chitu","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.tins.2025.06.008_bb0145","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/glia.10161","article-title":"Microglia as a source and target of cytokines","volume":"40","author":"Hanisch","year":"2002","journal-title":"Glia"},{"key":"10.1016\/j.tins.2025.06.008_bb0150","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/jnc.12244","article-title":"Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells","volume":"126","author":"Urrutia","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tins.2025.06.008_bb0155","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12974-017-1052-x","article-title":"Porphyromonas gingivalis lipopolysaccharide induces cognitive dysfunction, mediated by neuronal inflammation via activation of the TLR4 signaling pathway in C57BL\/6 mice","volume":"15","author":"Zhang","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.tins.2025.06.008_bb0160","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S0002-9440(10)63724-8","article-title":"12\/15-Lipoxygenase is increased in Alzheimer's disease: possible involvement in brain oxidative stress","volume":"164","author":"Pratic\u00f2","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tins.2025.06.008_bb0165","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0165-5728(01)00438-6","article-title":"Microarray analysis of gene expression in multiple sclerosis and EAE identifies 5-lipoxygenase as a component of inflammatory lesions","volume":"121","author":"Whitney","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.tins.2025.06.008_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106779","article-title":"ALOX5 inhibition protects against dopaminergic neurons undergoing ferroptosis","volume":"193","author":"Li","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.tins.2025.06.008_bb0175","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.tins.2020.10.008","article-title":"Signaling by cGAS\u2013STING in neurodegeneration, neuroinflammation, and aging","volume":"44","author":"Paul","year":"2021","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.tins.2025.06.008_bb0180","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41580-020-0244-x","article-title":"Molecular mechanisms and cellular functions of cGAS\u2013STING signalling","volume":"21","author":"Hopfner","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.tins.2025.06.008_bb0185","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1016\/j.cell.2024.05.031","article-title":"STING orchestrates the neuronal inflammatory stress response in multiple sclerosis","volume":"187","author":"Woo","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.tins.2025.06.008_bb0190","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1038\/s41418-023-01195-0","article-title":"Ferroptosis contributes to multiple sclerosis and its pharmacological targeting suppresses experimental disease progression","volume":"30","author":"Van San","year":"2023","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.tins.2025.06.008_bb0195","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.tins.2025.06.008_bb0200","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.tins.2025.06.008_bb0205","article-title":"Amyotrophic lateral sclerosis","volume":"3","author":"Hardiman","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.tins.2025.06.008_bb0210","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nm0896-864","article-title":"Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease","volume":"2","author":"Scheuner","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.tins.2025.06.008_bb0215","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0896-6273(00)80230-5","article-title":"Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42\/1-40 ratio in vitro and in vivo","volume":"17","author":"Borchelt","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2025.06.008_bb0220","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/383710a0","article-title":"Increased amyloid-\u03b242(43) in brains of mice expressing mutant presenilin 1","volume":"383","author":"Duff","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.tins.2025.06.008_bb0225","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nm0197-67","article-title":"Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice","volume":"3","author":"Citron","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.tins.2025.06.008_bb0230","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/s41419-024-07152-0","article-title":"The link between amyloid \u03b2 and ferroptosis pathway in Alzheimer's disease progression","volume":"15","author":"Majern\u00edkov\u00e1","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tins.2025.06.008_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2022.01.002","article-title":"Enhanced defense against ferroptosis ameliorates cognitive impairment and reduces neurodegeneration in 5xFAD mice","volume":"180","author":"Chen","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tins.2025.06.008_bb0240","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41580-024-00753-9","article-title":"Cellular and pathological functions of tau","volume":"25","author":"Parra Bravo","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.tins.2025.06.008_bb0245","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.cell.2021.12.041","article-title":"Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration","volume":"185","author":"Tracy","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.tins.2025.06.008_bb0250","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3233\/JAD-170168","article-title":"Extracellular tau oligomers induce invasion of endogenous tau into the somatodendritic compartment and axonal transport dysfunction","volume":"58","author":"Swanson","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.tins.2025.06.008_bb0255","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/nn.4328","article-title":"Neuronal activity enhances tau propagation and tau pathology in vivo","volume":"19","author":"Wu","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tins.2025.06.008_bb0260","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1007\/s12035-022-02731-8","article-title":"Ferroptosis promotes microtubule-associated protein tau aggregation via GSK-3\u03b2 activation and proteasome inhibition","volume":"59","author":"Wang","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.tins.2025.06.008_bb0265","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nm.2613","article-title":"Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export","volume":"18","author":"Lei","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.tins.2025.06.008_bb0270","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1038\/s41380-020-0762-0","article-title":"Amyloidogenic processing of Alzheimer's disease \u03b2-amyloid precursor protein induces cellular iron retention","volume":"25","author":"Tsatsanis","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tins.2025.06.008_bb0275","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.cell.2010.08.014","article-title":"Iron-export ferroxidase activity of \u03b2-amyloid precursor protein is inhibited by zinc in Alzheimer's disease","volume":"142","author":"Duce","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.tins.2025.06.008_bb0280","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.cell.2019.04.001","article-title":"Neuron\u2013astrocyte metabolic coupling protects against activity-induced fatty acid toxicity","volume":"177","author":"Ioannou","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.tins.2025.06.008_bb0285","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.cmet.2017.08.024","article-title":"The glia\u2013neuron lactate shuttle and elevated ROS promote lipid synthesis in neurons and lipid droplet accumulation in glia via APOE\/D","volume":"26","author":"Liu","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.tins.2025.06.008_bb0290","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0896-6273(02)00789-4","article-title":"Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration","volume":"35","author":"Higuchi","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2025.06.008_bb0295","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/s41593-020-00728-x","article-title":"Tau accumulation in astrocytes of the dentate gyrus induces neuronal dysfunction and memory deficits in Alzheimer's disease","volume":"23","author":"Richetin","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tins.2025.06.008_bb0300","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1038\/s41593-024-01740-1","article-title":"Tau is required for glial lipid droplet formation and resistance to neuronal oxidative stress","volume":"27","author":"Goodman","year":"2024","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tins.2025.06.008_bb0305","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41583-020-00416-6","article-title":"Reverse engineering Lewy bodies: how far have we come and how far can we go?","volume":"22","author":"Fares","year":"2021","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tins.2025.06.008_bb0310","doi-asserted-by":"crossref","first-page":"17497","DOI":"10.1074\/jbc.RA120.013428","article-title":"Fibrillar \u03b1-synuclein toxicity depends on functional lysosomes","volume":"295","author":"Guiney","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tins.2025.06.008_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111231","article-title":"Alpha synuclein determines ferroptosis sensitivity in dopaminergic neurons via modulation of ether-phospholipid membrane composition","volume":"40","author":"Mahoney-Sanchez","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.tins.2025.06.008_bb0320","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41586-020-2732-8","article-title":"Plasticity of ether lipids promotes ferroptosis susceptibility and evasion","volume":"585","author":"Zou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.tins.2025.06.008_bb0325","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s004010050001","article-title":"Sequestration of iron by Lewy bodies in Parkinson's disease","volume":"100","author":"Castellani","year":"2000","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tins.2025.06.008_bb0330","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1212\/WNL.51.3.887","article-title":"Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for alpha-synuclein","volume":"51","author":"Arawaka","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.tins.2025.06.008_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110358","article-title":"Interleukin-6 triggers toxic neuronal iron sequestration in response to pathological \u03b1-synuclein","volume":"38","author":"Sterling","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.tins.2025.06.008_bb0340","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.expneurol.2013.03.017","article-title":"Chronic intranasal deferoxamine ameliorates motor defects and pathology in the \u03b1-synuclein rAAV Parkinson's model","volume":"247","author":"Febbraro","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.tins.2025.06.008_bb0345","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1002\/ana.410320718","article-title":"Role of iron and iron chelation in dopaminergic-induced neurodegeneration: implication for Parkinson's disease","volume":"32","author":"Ben-Shachar","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tins.2025.06.008_bb0350","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0896-6273(03)00126-0","article-title":"Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease","volume":"37","author":"Kaur","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2025.06.008_bb0355","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/ars.2013.5593","article-title":"Targeting chelatable iron as a therapeutic modality in Parkinson's disease","volume":"21","author":"Devos","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.tins.2025.06.008_bb0360","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/s41598-017-01402-2","article-title":"Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson's disease","volume":"7","author":"Martin-Bastida","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tins.2025.06.008_bb0365","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.tins.2021.02.008","article-title":"Connecting TDP-43 pathology with neuropathy","volume":"44","author":"Klim","year":"2021","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.tins.2025.06.008_bb0370","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.tins.2025.06.008_bb0375","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/s41418-021-00910-z","article-title":"Ferroptosis mediates selective motor neuron death in amyotrophic lateral sclerosis","volume":"29","author":"Wang","year":"2022","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.tins.2025.06.008_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103301","article-title":"TDP-43 dysfunction leads to bioenergetic failure and lipid metabolic rewiring in human cells","volume":"75","author":"Ceron-Codorniu","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.tins.2025.06.008_bb0385","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/s41583-022-00564-x","article-title":"Modelling amyotrophic lateral sclerosis in rodents","volume":"23","author":"Todd","year":"2022","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tins.2025.06.008_bb0390","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.neuron.2025.03.004","article-title":"TDP-43 seeding induces cytoplasmic aggregation heterogeneity and nuclear loss of function of TDP-43","volume":"113","author":"Rummens","year":"2025","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2025.06.008_bb0395","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.bbadis.2014.08.010","article-title":"Sporadic and hereditary amyotrophic lateral sclerosis (ALS)","volume":"1852","author":"Ajroud-Driss","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tins.2025.06.008_bb0400","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.tibs.2006.12.005","article-title":"How do ALS-associated mutations in superoxide dismutase 1 promote aggregation of the protein?","volume":"32","author":"Shaw","year":"2007","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.tins.2025.06.008_bb0405","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0896-6273(00)80272-X","article-title":"ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions","volume":"18","author":"Bruijn","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2025.06.008_bb0410","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1093\/hmg\/ddv093","article-title":"A cysteine residue affects the conformational state and neuronal toxicity of mutant SOD1 in mice: relevance to the pathogenesis of ALS","volume":"24","author":"Nagano","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tins.2025.06.008_bb0415","doi-asserted-by":"crossref","DOI":"10.4028\/b-wjQRP6","article-title":"Amyloid fibril structures and ferroptosis activation induced by ALS-causing SOD1 mutations","volume":"10","author":"Wang","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.tins.2025.06.008_bb0420","article-title":"Overexpression of ferroptosis defense enzyme Gpx4 retards motor neuron disease of SOD1G93A mice","volume":"11","author":"Chen","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tins.2025.06.008_bb0425","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1083\/jcb.201803152","article-title":"Fueling thought: management of glycolysis and oxidative phosphorylation in neuronal metabolism","volume":"217","author":"Yellen","year":"2018","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.tins.2025.06.008_bb0430","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1083\/jcb.200809125","article-title":"Parkin is recruited selectively to impaired mitochondria and promotes their autophagy","volume":"183","author":"Narendra","year":"2008","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.tins.2025.06.008_bb0435","series-title":"Mitophagy in Health and Disease","first-page":"83","article-title":"The mitochondrial unfolded protein response in health and disease","author":"Safakli","year":"2025"},{"key":"10.1016\/j.tins.2025.06.008_bb0440","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/nrm3479","article-title":"Mitochondria: master regulators of danger signalling","volume":"13","author":"Galluzzi","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.tins.2025.06.008_bb0445","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/s41586-025-08756-y","article-title":"Oxidation of retromer complex controls mitochondrial translation","volume":"641","author":"Zhang","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.tins.2025.06.008_bb0450","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3233\/JPD-161020","article-title":"VPS35, the retromer complex and Parkinson's disease","volume":"7","author":"Williams","year":"2017","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.tins.2025.06.008_bb0455","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.nbd.2009.02.005","article-title":"Inhibition of mitochondrial function induces an integrated stress response in oligodendroglia","volume":"34","author":"Silva","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tins.2025.06.008_bb0460","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.cmet.2021.02.001","article-title":"Asparagine couples mitochondrial respiration to ATF4 activity and tumor growth","volume":"33","author":"Krall","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.tins.2025.06.008_bb0465","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.cmet.2022.08.017","article-title":"OMA1-mediated integrated stress response protects against ferroptosis in mitochondrial cardiomyopathy","volume":"34","author":"Ahola","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.tins.2025.06.008_bb0470","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.molcel.2018.10.042","article-title":"Role of mitochondria in ferroptosis","volume":"73","author":"Gao","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tins.2025.06.008_bb0475","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/j.molcel.2024.04.009","article-title":"Unraveling ETC complex I function in ferroptosis reveals a potential ferroptosis-inducing therapeutic strategy for LKB1-deficient cancers","volume":"84","author":"Mao","year":"2024","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tins.2025.06.008_bb0480","doi-asserted-by":"crossref","first-page":"9089","DOI":"10.1074\/jbc.M710012200","article-title":"Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain","volume":"283","author":"Devi","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tins.2025.06.008_bb0485","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/brain\/awq015","article-title":"Mechanism of neurodegeneration of neurons with mitochondrial DNA mutations","volume":"133","author":"Abramov","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.tins.2025.06.008_bb0490","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/s41586-021-04059-0","article-title":"Disruption of mitochondrial complex I induces progressive parkinsonism","volume":"599","author":"Gonz\u00e1lez-Rodr\u00edguez","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.tins.2025.06.008_bb0495","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.30952","article-title":"Transcriptomic and proteomic landscape of mitochondrial dysfunction reveals secondary coenzyme Q deficiency in mammals","volume":"6","author":"K\u00fchl","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.tins.2025.06.008_bb0500","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","article-title":"FSP1 is a glutathione-independent ferroptosis suppressor","volume":"575","author":"Doll","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.tins.2025.06.008_bb0505","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","article-title":"The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis","volume":"575","author":"Bersuker","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.tins.2025.06.008_bb0510","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/s41583-025-00908-3","article-title":"Lipid metabolism, remodelling and intercellular transfer in the CNS","volume":"26","author":"Vanherle","year":"2025","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tins.2025.06.008_bb0515","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrn3820","article-title":"Polyunsaturated fatty acids and their metabolites in brain function and disease","volume":"15","author":"Bazinet","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tins.2025.06.008_bb0520","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","article-title":"Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies","volume":"18","author":"Nalls","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.tins.2025.06.008_bb0525","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","article-title":"New insights into the genetic etiology of Alzheimer's disease and related dementias","volume":"54","author":"Bellenguez","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tins.2025.06.008_bb0530","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium","volume":"278","author":"Farrer","year":"1997","journal-title":"Jama"},{"key":"10.1016\/j.tins.2025.06.008_bb0535","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.tins.2025.06.008_bb0540","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13024-025-00843-y","article-title":"Apolipoprotein E in Alzheimer's disease: molecular insights and therapeutic opportunities","volume":"20","author":"Belaidi","year":"2025","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tins.2025.06.008_bb0545","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41380-022-01568-w","article-title":"Apolipoprotein E potently inhibits ferroptosis by blocking ferritinophagy","volume":"29","author":"Belaidi","year":"2024","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tins.2025.06.008_bb0550","article-title":"Protective ApoE variants support neuronal function by extracting peroxidated lipids","author":"Ralhan","year":"2025","journal-title":"BioRxiv"},{"key":"10.1016\/j.tins.2025.06.008_bb0555","doi-asserted-by":"crossref","first-page":"5944","DOI":"10.1021\/cr200084z","article-title":"Free radical lipid peroxidation: mechanisms and analysis","volume":"111","author":"Yin","year":"2011","journal-title":"Chem. Rev."},{"key":"10.1016\/j.tins.2025.06.008_bb0560","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1146\/annurev-biochem-052521-033527","article-title":"Lipid quality control and ferroptosis: from concept to mechanism","volume":"93","author":"Li","year":"2024","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.tins.2025.06.008_bb0565","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.addr.2020.01.004","article-title":"Fatty acid metabolism in the progression and resolution of CNS disorders","volume":"159","author":"Bogie","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.tins.2025.06.008_bb0570","doi-asserted-by":"crossref","first-page":"49874","DOI":"10.1074\/jbc.M309127200","article-title":"Altered fatty acid composition of dopaminergic neurons expressing alpha-synuclein and human brains with alpha-synucleinopathies","volume":"278","author":"Sharon","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tins.2025.06.008_bb0575","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1007\/s13311-023-01382-4","article-title":"Inhibition of ACSL4 alleviates Parkinsonism phenotypes by reduction of lipid reactive oxygen species","volume":"20","author":"Tang","year":"2023","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.tins.2025.06.008_bb0580","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-025-05006-0","article-title":"SCD1-mediated lipid metabolism alleviates neuronal ferroptosis in subarachnoid hemorrhage: role of oleic acid supplementation","author":"Zhou","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.tins.2025.06.008_bb0585","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.chembiol.2023.10.012","article-title":"Ferroptosis inhibition by oleic acid mitigates iron-overload-induced injury","volume":"31","author":"Mann","year":"2024","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.tins.2025.06.008_bb0590","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.stem.2015.08.001","article-title":"Aberrant lipid metabolism in the forebrain niche suppresses adult neural stem cell proliferation in an animal model of Alzheimer\u2019s disease","volume":"17","author":"Hamilton","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.tins.2025.06.008_bb0595","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/s41556-024-01361-7","article-title":"Ironing out the details of ferroptosis","volume":"26","author":"Zhang","year":"2024","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.tins.2025.06.008_bb0610","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1111\/j.1460-9568.2005.04083.x","article-title":"Recognition memory impairment and brain oxidative stress induced by postnatal iron administration","volume":"21","author":"de Lima","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.tins.2025.06.008_bb0615","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1353-8020(00)00028-6","article-title":"Neonatal iron potentiates adult MPTP-induced neurodegenerative and functional deficits","volume":"7","author":"Fredriksson","year":"2001","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.tins.2025.06.008_bb0620","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.neurobiolaging.2006.04.003","article-title":"Increased murine neonatal iron intake results in Parkinson-like neurodegeneration with age","volume":"28","author":"Kaur","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.tins.2025.06.008_bb0625","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3389\/fnagi.2015.00206","article-title":"Behavioral and neurochemical deficits in aging rats with increased neonatal iron intake: silibinin's neuroprotection by maintaining redox balance","volume":"7","author":"Chen","year":"2015","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.tins.2025.06.008_bb0630","doi-asserted-by":"crossref","first-page":"6760","DOI":"10.1038\/ncomms7760","article-title":"Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE","volume":"6","author":"Ayton","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tins.2025.06.008_bb0635","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/jnnp-2022-330052","article-title":"CSF ferritin in the clinicopathological progression of Alzheimer's disease and associations with APOE and inflammation biomarkers","volume":"94","author":"Ayton","year":"2023","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.tins.2025.06.008_bb0640","doi-asserted-by":"crossref","DOI":"10.1002\/alz70855_105930","article-title":"Iron-associated lipid peroxidation in Alzheimer's disease is increased in lipid rafts with decreased ferroptosis suppressors, tested by chelation in mice","volume":"21","author":"Thorwald","year":"2025","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tins.2025.06.008_bb0645","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s12017-017-8447-9","article-title":"Deferiprone rescues behavioral deficits induced by mild iron exposure in a mouse model of alpha-synuclein aggregation","volume":"19","author":"Carboni","year":"2017","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.tins.2025.06.008_bb0650","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s13346-011-0050-2","article-title":"Intranasal delivery of deferoxamine reduces spatial memory loss in APP\/PS1 mice","volume":"2","author":"Hanson","year":"2012","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.tins.2025.06.008_bb0655","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.neurobiolaging.2012.05.009","article-title":"Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease","volume":"34","author":"Guo","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.tins.2025.06.008_bb0660","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41580-023-00648-1","article-title":"Mechanisms controlling cellular and systemic iron homeostasis","volume":"25","author":"Galy","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.tins.2025.06.008_bb0665","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1038\/s41556-023-01225-6","article-title":"Iron drives anabolic metabolism through active histone demethylation and mTORC1","volume":"25","author":"Shapiro","year":"2023","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.tins.2025.06.008_bb0670","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41589-018-0031-6","article-title":"FINO2 initiates ferroptosis through GPX4 inactivation and iron oxidation","volume":"14","author":"Gaschler","year":"2018","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.tins.2025.06.008_bb0675","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.chembiol.2018.11.016","article-title":"Exogenous monounsaturated fatty acids promote a ferroptosis-resistant cell state","volume":"26","author":"Magtanong","year":"2019","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.tins.2025.06.008_bb0680","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ccell.2022.02.003","article-title":"CD8+ T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4","volume":"40","author":"Liao","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tins.2025.06.008_bb0685","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s41586-022-05022-3","article-title":"A non-canonical vitamin K cycle is a potent ferroptosis suppressor","volume":"608","author":"Mishima","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.tins.2025.06.008_bb0690","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114930","article-title":"Vitamin A metabolites inhibit ferroptosis","volume":"164","author":"Jakaria","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.tins.2025.06.008_bb0695","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.redox.2016.05.003","article-title":"Glutathione peroxidase 4 and vitamin E cooperatively prevent hepatocellular degeneration","volume":"9","author":"Carlson","year":"2016","journal-title":"Redox Biol."},{"key":"10.1016\/j.tins.2025.06.008_bb0700","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s00204-015-1517-6","article-title":"Biomarkers of lipid peroxidation in Alzheimer disease (AD): an update","volume":"89","author":"Bradley-Whitman","year":"2015","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tins.2025.06.008_bb0705","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac215","article-title":"Hippocampal glutathione depletion with enhanced iron level in patients with mild cognitive impairment and Alzheimer's disease compared with healthy elderly participants","volume":"4","author":"Mandal","year":"2022","journal-title":"Brain Commun."},{"key":"10.1016\/j.tins.2025.06.008_bb0710","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1038\/s41380-019-0375-7","article-title":"Brain iron is associated with accelerated cognitive decline in people with Alzheimer pathology","volume":"25","author":"Ayton","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tins.2025.06.008_bb0715","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1471-4159.1989.tb09133.x","article-title":"Basal lipid peroxidation in substantia nigra is increased in Parkinson\u2019s disease","volume":"52","author":"Dexter","year":"1989","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tins.2025.06.008_bb0720","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/BF01291884","article-title":"Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease","volume":"104","author":"Pearce","year":"1997","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.tins.2025.06.008_bb0725","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41531-021-00199-2","article-title":"Parkinson's disease multimodal imaging: F-DOPA PET, neuromelanin-sensitive and quantitative iron-sensitive MRI","volume":"7","author":"Depierreux","year":"2021","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.tins.2025.06.008_bb0730","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/ana.410440419","article-title":"Presence of 4-hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis","volume":"44","author":"Smith","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tins.2025.06.008_bb0735","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1212\/WNL.62.10.1758","article-title":"Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden","volume":"62","author":"Simpson","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.tins.2025.06.008_bb0740","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3390\/antiox10071011","article-title":"Glutathione in the nervous system as a potential therapeutic target to control the development and progression of amyotrophic lateral sclerosis","volume":"10","author":"Kim","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.tins.2025.06.008_bb0745","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0022-510X(95)00037-3","article-title":"Aluminum, calcium, and iron in the spinal cord of patients with sporadic amyotrophic lateral sclerosis using laser microprobe mass spectroscopy: a preliminary study","volume":"130","author":"Kasarskis","year":"1995","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.tins.2025.06.008_bb0750","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1148\/radiol.2018180112","article-title":"Quantitative susceptibility MRI to detect brain iron in amyotrophic lateral sclerosis","volume":"289","author":"Acosta-Cabronero","year":"2018","journal-title":"Radiology"},{"key":"10.1016\/j.tins.2025.06.008_bb0755","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abm5500","article-title":"G9a dictates neuronal vulnerability to inflammatory stress via transcriptional control of ferroptosis","volume":"8","author":"Rothammer","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.tins.2025.06.008_bb0760","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/1352458510384010","article-title":"Lower levels of glutathione in the brains of secondary progressive multiple sclerosis patients measured by 1H magnetic resonance chemical shift imaging at 3 T","volume":"17","author":"Choi","year":"2011","journal-title":"Mult. Scler."},{"key":"10.1016\/j.tins.2025.06.008_bb0765","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/bpa.12643","article-title":"Iron related changes in MS lesions and their validity to characterize MS lesion types and dynamics with ultra-high field magnetic resonance imaging","volume":"28","author":"Hametner","year":"2018","journal-title":"Brain Pathol."},{"key":"10.1016\/j.tins.2025.06.008_bb0770","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1471-4159.2011.07536.x","article-title":"Pathogenic implications of iron accumulation in multiple sclerosis","volume":"120","author":"Williams","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tins.2025.06.008_bb0775","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1016\/j.molcel.2023.09.025","article-title":"Identification of hyperoxidized PRDX3 as a ferroptosis marker reveals ferroptotic damage in chronic liver diseases","volume":"83","author":"Cui","year":"2023","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tins.2025.06.008_bb0780","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1016\/j.celrep.2020.02.049","article-title":"Transferrin receptor is a specific ferroptosis marker","volume":"30","author":"Feng","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.tins.2025.06.008_bb0785","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","article-title":"Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications","volume":"185","author":"Stockwell","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.tins.2025.06.008_bb0790","doi-asserted-by":"crossref","first-page":"D571","DOI":"10.1093\/nar\/gkac935","article-title":"FerrDb V2: update of the manually curated database of ferroptosis regulators and ferroptosis\u2013disease associations","volume":"51","author":"Zhou","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tins.2025.06.008_bb0795","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41586-024-07405-0","article-title":"Large-scale neurophysiology and single-cell profiling in human neuroscience","volume":"630","author":"Lee","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.tins.2025.06.008_bb0800","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1038\/s41593-024-01827-9","article-title":"Applying single-cell and single-nucleus genomics to studies of cellular heterogeneity and cell fate transitions in the nervous system","volume":"27","author":"Adameyko","year":"2024","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tins.2025.06.008_bb0805","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12915-025-02235-6","article-title":"Transcriptomic signatures of oxytosis\/ferroptosis are enriched in Alzheimer's disease","volume":"23","author":"Currais","year":"2025","journal-title":"BMC Biol."},{"key":"10.1016\/j.tins.2025.06.008_bb0810","doi-asserted-by":"crossref","first-page":"458","DOI":"10.14336\/AD.2016.1108","article-title":"Mitochondrial ferritin protects Hydrogen peroxide-induced neuronal cell damage","volume":"8","author":"Gao","year":"2017","journal-title":"Aging Dis."},{"key":"10.1016\/j.tins.2025.06.008_bb0815","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/0014-4886(60)90005-4","article-title":"Changes during growth in the volume and surface area of cortical neurons in the rabbit","volume":"2","author":"Schad\u00e9","year":"1960","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.tins.2025.06.008_bb0820","doi-asserted-by":"crossref","first-page":"18436","DOI":"10.1073\/pnas.1107936108","article-title":"Lipocalin-2 controls neuronal excitability and anxiety by regulating dendritic spine formation and maturation","volume":"108","author":"Mucha","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Trends in Neurosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166223625001389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166223625001389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T21:10:58Z","timestamp":1777497058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166223625001389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":162,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0166223625001389"],"URL":"https:\/\/doi.org\/10.1016\/j.tins.2025.06.008","relation":{},"ISSN":["0166-2236"],"issn-type":[{"value":"0166-2236","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Triggering ferroptosis in neurodegenerative diseases","name":"articletitle","label":"Article Title"},{"value":"Trends in Neurosciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tins.2025.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}